差别

这里会显示出您选择的修订版和å

到此差别页面的链接

两侧同时换到之前的修订记录 前一修订版
后一修订版 		前一修订版
概念:知情同意 [2022/02/25 03:41]
老T 		概念:知情同意 [2022/02/28 08:40] (当前版本)
老T
行 1: 行 1:
-====== 知情同意（Informed Consent） ======+====== 知情同意 Informed Consent ======
  
 \\ \\
-　　**知情同意**：指向受试者告知一项试验的各方面情况后，受试者自愿确认其同意参加该项临床试验的过程，须以签名和注明日期的知情同意书作为文件证明。(([[法规:药物临床试验质量管理规范|药物临床试验质量管理规范]]. （局令第3号）, 2003))+　　**知情同意**：指受试者被告知可影响其做出参加临床试验决定的各方面情况后，确认同意自愿参加临床试验的过程。该过程应当以书面的、签署姓名和日期的知情同意书作为文件证明。(([[法规:药物临床试验质量管理规范|药物临床试验质量管理规范]]. [[概念:国家药品监督管理局]]. 2020))  
 + 
 +　　**Informed Consent**: A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject's decision to participate. Informed consent is documented by means of a written, signed and dated informed consent form.(([[法规:ich-gcp|ICH GCP (E6(R2))]]. [[概念:ICH]]. 2016))
  
-　　**Informed Consent**: A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject's decision to participate. Informed consent is documented by means of a written, signed and dated informed consent form.(([[法规:ich-gcp|ICH-GCP]]. E6(R2), 2016)) 
 \\ \\
  
 ===== 扩展阅读 ===== ===== 扩展阅读 =====
  
-　　**FDA: [[法规:知情同意指南|知情同意指南（Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors）]]**+　　**1. FDA: [[法规:知情同意指南|知情同意指南（Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors）]]**
  
 \\ \\
  • 概念/知情同意.1645760464.txt
  • 最后更改: 2年前
  • 由 老T